Deutsche Bank’s Lisata Therapeutics LSTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-666
Closed -$25K 4602
2019
Q4
$25K Sell
666
-1,374
-67% -$49.4K ﹤0.01% 4236
2019
Q3
$79K Sell
2,040
-1,979
-49% -$76.9K ﹤0.01% 3685
2019
Q2
$137K Buy
4,019
+1,029
+34% +$45.7K ﹤0.01% 4050
2019
Q1
$162K Sell
2,990
-411
-12% -$27K ﹤0.01% 4104
2018
Q4
$181K Sell
3,401
-420
-11% -$29.2K ﹤0.01% 3926
2018
Q3
$338K Buy
3,821
+3,241
+559% +$266K ﹤0.01% 3980
2018
Q2
$56K Buy
+580
New +$40.9K ﹤0.01% 4746
2016
Q3
Sell
-40
Closed -$3K 5076
2016
Q2
$3K Hold
40
﹤0.01% 5056
2016
Q1
$4K Hold
40
﹤0.01% 4978
2015
Q4
$6K Buy
40
+13
+48% +$2.39K ﹤0.01% 5033
2015
Q3
$5K Sell
27
-7
-21% -$1.76K ﹤0.01% 5047
2015
Q2
$9K Buy
+34
New +$12.6K ﹤0.01% 5065
2015
Q1
Hold
0
5638
2014
Q4
Sell
-2
Closed -$1.36K 6247
2014
Q3
$1K Buy
2
+1
+100% +$875 ﹤0.01% 5764
2014
Q2
$0 Buy
+1
New +$972 ﹤0.01% 5966
2013
Q4
Sell
-27
Closed -$35K 5569
2013
Q3
$35K Buy
+27
New +$30K ﹤0.01% 4782

Other funds holding LSTA

Deutsche Bank's LSTA Position: Q1 2020 in Review

Deutsche Bank sold out of Lisata Therapeutics (LSTA) in Q1 2020, closing a stake of 666 shares — an estimated $25K sold.

Deutsche Bank first reported a position in LSTA in Q3 2013 and held it in 15 quarters. The position peaked at $338K in Q3 2018. 24 funds tracked by Wall St. Rank hold LSTA as of Q1 2020.

  • Deutsche Bank reported no remaining Lisata Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Deutsche Bank sold 666 Lisata Therapeutics shares in Q1 2020, an estimated $25K.
  • Deutsche Bank first reported a position in Lisata Therapeutics in Q3 2013 and held it in 15 quarters.
  • Deutsche Bank's Lisata Therapeutics position peaked at $338K in Q3 2018.
  • 24 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2020.

Based on Deutsche Bank's 13F filing for Q1 2020, filed 14 May 2020.